MYR Group Inc

MYRG remains in a persistent Stage 3 decline with a clear sequence of lower highs and lower lows under declining EMAs. Price is oversold (OS tag) but shows no reliable bounce or mean‐reversion setup. Medium‐term bias is bearish, and execution is best deferred until any rally into the declining 9/20 EMA zone for potential rejection.

• ↑Q2 revenue $1.08B (+20% YoY) with net income $50M (+86% YoY).
• ↑Backlog at $3.16B (+20% YoY) underpins strong forward visibility.
• ↓Free cash flow was -$26M vs. positive prior year.